Copper

Encyclopedia of Dietary Supplements

Volumn , Issue , 2004, Pages 133-141

  Klevay, Leslie M ^a  

^a GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60849099782     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1081/E-EDS-120022059     Document Type: Chapter

References (118)

1. Linder, M.C. Copper. In Present Knowledge in Nutrition, 7th Ed.; Ziegler, E.E., Filer, L.J. Jr., Eds.; ISLI Press: Washington, 1996; 307–319.
2. Owen, C.A. Jr. Biochemical aspects of copper. Noyes Publications: ParkRidge, N.J., 1982; 1–205.
3. Prohaska, J.R., Biochemical changes in copper deficiency. J. Nutr. Biochem. 1990, 1, 452–461.
4. O’Halloran, T.V.; Culotta, V.C.; Metallochaperones, an intracellular shuttle service for metal ions. J. Biol. Chem. 2000, 275, 25057–25060.
5. May, P.M.; Linder, P.W.; Williams, D.R. Ambivalent effect of protein binding on computed distributions of metal ions complexed by ligands in blood plasma. Experientia 1976, 32, 1492–1494.
6. May, P.M.; Linder, P.W.; Williams, D.R. Computer simulation of metal–ion equilibria in biofluids: models for the low-molecular-weight complex distribution of calcium(II), magnesium(II), manganese(II), iron(III), copper(II), zinc(II), and lead(II) ions in blood plasma. J. Chem. Soc. Dalton Trans. 1977, 588–595.
7. Hart, E.B.; Steenbock, H.; Waddell, J.; Elvehjem, C.A. Iron in nutrition. VII. Copper as a supplement to iron for hemoglobin building in the rat. J. Biol. Chem. 1928, 77, 797–812.
8. Lynch, S.M.; Klevay, L.M.; Effects of a dietary copper deficiency on plasma coagulation factor activities in male and female mice. J. Nutr. Biochem. 1992, 3, 387–391.
9. Mann, K.G.; Lawler, C.M.; Vehar, G.A.; Church, W.R.; Coagulation factor V contains copper ion. J. Biol. Chem. 1984, 259, 12949–12951.
10. Linder, M.C.; Goode, C.A.; 6.4 Specific copper components in special tissues. In Biochemistry of Copper; Plenum Press: New York, 1991; 212–220.
11. Davis, G.K.; Mertz, W. Copper. In Trace Elements in Human and Animal Nutrition, 5th Ed.; Mertz, W., Ed.; Academic Press: San Diego, 1986; 301–364.
12. Klevay, L.M. Ischemic heart disease: toward a unified theory. In Role of Copper in Lipid Metabolism; Lei, K.Y., Carr, T.P., Eds.; CRC Press: Boca Raton, FL, 1990; 233–267.
13. Klevay, L.M. Trace element and mineral nutrition in disease: ischemic heart disease. In In Clinical Nutrition of the Essential Trace Elements and Minerals: The Guide for Health Professionals; Bogden, J.D., Klevay, L.M., Eds.; Humana Press, Inc.: Totowa, NJ, 2000; 251–271.
14. Klevay, L.M.; Wildman, R.E. Meat diets and fragile bones: inferences about osteoporosis. J. Trace Elem. Med. Biol. 2002, 16, 149–154.
15. Davis, C.D.; Feng, Y.; Dietary copper, manganese and iron affect the formation of aberrant crypts in colon of rats administered 3,20- dimethyl-4-aminobiphenyl. J. Nutr. 1999, 129, 1060–1067.
16. Fields, M.; Lewis, C.G.; Bureau, I. Aspirin reduces blood cholesterol in copper-deficient rats: a potential antioxidant agent Metabolism 2001, 50, 558–561.
17. Wildman, R.E.; Mao, S.; Tissue-specific alterations in lipoprotein lipase activity in copperdeficient rats. Biol. Trace Elem. Res. 2001, 80, 221–229.
18. Klevay, L.M.; Hypercholesterolemia in rats produced by an increase in the ratio of zinc to copper ingested. Am. J. Clin. Nutr. 1973, 26, 1060–1068.
19. Cappel, R.E.; Gilbert, H.F.; Thiol/disulfide exchange between 3-hydroxy-3-methylglutaryl- CoA reductase and glutathione. A thermodynamically facile dithiol oxidation. J. Biol. Chem. 1988, 263, 12204–12212.
20. Cappel, R.E.; Gilbert, H.F.; Oxidative inactivation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and subunit cross-linking involve different dithiol=disulfide centers. J. Biol. Chem. 1993, 268, 342–348.
21. Allen, K.G.; Klevay, L.M. Copper: an antioxidant nutrient for cardiovascular health. Curr. Opin. Lipidol. 1994, 5, 22–28.
22. Valsala, P.; Kurup, P.A. Investigations on the mechanism of hypercholesterolemia observed in copper deficiency in rats. J. Biosci. 1987, 12, 137–142.
23. Yount, N.Y.; McNamara, D.J.; Al Othman, A.A.; Lei, K.Y. The effect of copper deficiency on rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. J. Nutr. Biochem. 1990, 1, 21–27.
24. Kim, S.; Chao, P.Y.; Allen, K.G. Inhibition of elevated hepatic glutathione abolishes copper deficiency cholesterolemia. FASEB J. 1992, 6, 2467–2471.
25. Lau, B.W.; Klevay, L.M. Plasma lecithin: cholesterol acyltransferase in copper-deficient rats. J. Nutr. 1981, 111, 1698–1703.
26. Lau, B.W.; Klevay, L.M. Postheparin plasma lipoprotein lipase in copper-deficient rats. J. Nutr. 1982, 112, 928–933.
27. Huang, W.; Lai, C.; Wang, Y.; Askari, A.; Klevay, L.M.; Chiu, T.H. Altered expressions of cardiac Na=K-ATPase isoforms in copper deficient rats. Cardiovasc. Res. 1995, 29, 563–568.
28. Saari, J.T.; Dietary copper deficiency and endothelium-dependent relaxation of rat aorta. Proc. Soc. Exp. Biol. Med. 1992, 200, 19–24.
29. Lynch, S.M.; Frei, B.; Morrow, J.D.; Roberts, L.J.; Xu, A.; Jackson, T.; Reyna, R.; Klevay, L.M.; Vita, J.A.; Keaney, J.F., Jr.; Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 2975–2981.
30. Anon Decreased dietary copper impairs vascular function. Nutr. Rev. 1993, 51, 188–189.
31. Gerzer, R.; Bӧhme, E.; Hofmann, F.; Schultz, G. Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett. 1981, 132, 71–74.
32. Cunnane, S.C. Modulation of long chain fatty acid unsaturation by dietary copper. In Copper Bioavailability and Metabolism; Kies, C., Ed.; Plenum Press: New York, 1989; 183.
33. Cunnane, S.C. Copper and long chain fatty acid metabolism. In Role of Copper in Lipid Metabolism; Lei, K.Y., Carr, T.P., Eds.; CRC Press: Boca Raton, FL, 1990; 161–178.
34. Gibson, R.S.; Scythes, C.A. Trace element intakes of women. Br. J. Nutr. 1982, 48, 241–248.
35. Klevay, L.M.; Buchet, J.P.; Bunker, V.W.; Clayton, B.E.; Gibson, R.S.; Medeiros, D.M.; Moser-Veillon, P.B.; Patterson, K.Y.; Taper, L.J.; Wolf, W.R. Copper in the Western diet (Belgium, Canada, UK and USA). In Trace Elements in Man and Animals, TEMA 8; Anke, M., Meissner, D., Mills, C.F., Eds.; Verlag Media Touristik: Gersdorf, Germany, 1993; 207–210.
36. Klevay, L.M.; Hypocholesterolemia due to sodium phytate. Nutr. Rep. Int. 1977, 15, 587–595.
37. Lurie, D.G.; Holden, J.M.; Schubert, A.; Wolf, W.R.; Miller-Ihli, N.J. The copper content of foods based on a critical evaluation of published analytical data. J. Food Comp. Anal. 1989, 2, 298–316.
38. Klevay, L.M.; Lack of a recommended dietary allowance for copper may be hazardous to your health. J. Am. Coll. Nutr. 1998, 17, 322–326.
39. Subar, A.F.; Krebs, S.S.; Cook, A.; Kahle, L.L.; Dietary sources of nutrients among US adults, 1989 to 1991. J. Am. Diet. Assoc. 1998, 98, 537–547.
40. Klevay, L.M.; Inman, L.; Johnson, L.K.; Lawler, M.; Mahalko, J.R.; Milne, D.B.; Lukaski, H.C.; Bolonchuk, W.; Sandstead, H.H. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 1984, 33, 1112–1118.
41. Reiser, S.; Smith, J.C., Jr.; Mertz, W.; Holbrook, J.T.; Scholfield, D.J.; Powell, A.S.; Canfield, W.K.; Canary, J.J. Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am. J. Clin. Nutr. 1985, 42, 242–251.
42. Klevay, L.M.; Canfield, W.K.; Gallagher, S.K.; Henriksen, L.K.; Lukaski, H.C.; Bolonchuk, W.; Johnson, L.K.; Milne, D.B.; Sandstead, H.H.; Decreased glucose tolerance in two men during experimental copper depletion. Nutr. Rep. Int. 1986, 33, 371–382.
43. Reiser, S.; Powell, A.; Yang, C.Y.; Canary, J.J.; Effect of copper intake on blood cholesterol and its lipoprotein distribution in men. Nutr. Rep. Int. 1987, 36, 641–649.
44. Lukaski, H.C.; Klevay, L.M.; Milne, D.B. Effects of dietary copper on human autonomic cardiovascular function. Eur. J. Appl. Physiol. 1988, 58, 74–80.
45. Anon. In Recommended Dietary Allowances; 10th Ed.; National Academy Press: Washington DC, 1989; 284.
46. Anon; Copper. In Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc; National Academy of Sciences: Washington, DC, 2001; 177–204.
47. Rawson, J.R.; Medeiros, D.M. Macronutrient, copper and zinc intakes of young adult males as determined by duplicate food samples and diet records. Nutr. Rep. Int. 1989, 39, 1149–1159.
48. Hunt, J.R.; Vanderpool, R.A. Apparent copper absorption from a vegetarian diet. Am. J. Clin. Nutr. 2001, 74, 803–807.
49. Anon; In Dietary Reference Intakes for Vitamin A, VitaminK, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc; National Academy of Sciences: Washington, DC, 2001; 773.
50. Pang, Y.; MacIntosh, D.L.; Ryan, P.B.; A longitudinal investigation of aggregate oral intake of copper. J. Nutr. 2001, 131, 2171–2176.
51. Klevay, L.M.; Soy protein may affect plasma cholesterol through copper. Am. J. Clin. Nutr. 1994, 60, 300–301.
52. Klevay, L.M.; Copper in nuts may lower heart disease risk. Arch. Intern. Med. 1993, 153, 401–402.
53. Klevay, L.M.; Copper in legumes may lower heart disease risk. Arch. Intern. Med. 2002, 162, 1780.
54. Klevay, L.M.; Moore, R.J. Beer mitigates some effects of copper deficiency in rats. Am. J. Clin. Nutr. 1990, 51, 869–872.
55. Anon; In Drug Information for the Health Care Professional: USP DI, 20th Ed.; World Color Book Services: Versailles, KY, 2000; 986–988.
56. Klevay, L.M.; Saari, J.T.; Comparative responses of rats to different copper intakes and modes of supplementation. Proc. Soc. Exp. Biol. Med. 1993, 203, 214–220.
57. Rock, E.; Mazur, A.; O’Connor, J.M.; Bonham, M.P.; Rayssiguier, Y.; Strain, J.J. The effect of copper supplementation on red blood cell oxidizability and plasma antioxidants in middleaged healthy volunteers. Free Radical Biol. Med. 2000, 28, 324–329.
58. Baker, D.H.; Cupric oxide should not be used as a copper supplement for either animals or humans. J. Nutr. 1999, 129, 2278–2279.
59. Burkitt, D.P. Western diseases and what they encompass. In Western Diseases: Their Dietary Prevention and Reversibility; Temple, N.J., Burkitt, D.P., Eds.; Humana Press: Totowa, NJ, 1994; 15–27.
60. Evans, G.W.; Cornatzer, N.F.; Cornatzer, W.E. Mechanism for hormone-induced alterations in serum ceruloplasmin. Am. J. Physiol. 1970, 218, 613–615.
61. Kincaid, R.L.; Toxicity of ammonium molyblate added to drinking water of calves. J. Diary Sci. 1980, 63, 608–610.
62. Klevay, L.M.; Metabolic interactions among cholesterol, cholic acid and copper. Nutr. Rep. Int. 1982, 26, 405–414.
63. Kennedy, M.L.; Failla, M.L.; Smith, J.C. Jr.; Influence of genetic obesity on tissue concentrations of zinc, copper, manganese and iron in mice. J. Nutr. 1986, 116, 1432–1441.
64. Clegg, M.S.; Ferrell, F.; Keen, C.L. Hypertension- induced alterations in copper and zinc metabolism in Dahl rats. Hypertension 1987, 9, 624–628.
65. Klevay, L.M.; Dietary cholesterol lowers liver copper in rabbits. Biol. Trace Elem. Res. 1988, 16, 51–57.
66. Vlad, M.; Bordas, E.; Tornus, R.; Sava, D.; Farkas, E.; Uza, G. Effect of copper sulfate on experimental atherosclerosis. Biol. Trace Elem. Res. 1993, 38, 47–54.
67. Vlad, M.; Uza, G.; Zirbo, M.; Olteanu, D. Free radicals, ceruloplasmin, and copper concentration in serum and aortic tissue in experimental atherosclerosis. Nutrition 1995, 11, 588–591.
68. Xu, H.; Sakakibara, S.; Morifuji, M.; Salamatulla, Q.; Aoyama, Y.; Excess dietary histidine decreases the liver copper level and serum alanine aminotransferase activity in Long–Evans Cinnamon rats. Br. J. Nutr. 2003, 90, 573–579.
69. Mills, C.F. Changing perspectives in studies of the trace elements and animal health. In Trace Elements in Man and Animals, TEMA 5; Mills, C.F., Bremner, I., Chesters, J.K., Eds.; Commonwealth Agricultural Bureaux: Farnham Royal, U.K., 1985; 1–10.
70. Gregg, X.T.; Reddy, V.; Prchal, J.T. Copper deficiency masquerading as myelodysplastic syndrome. Blood 2002, 100, 1493–1495.
71. Turnlund, J.R.; Keyes, W.R.; Anderson, H.L.; Acord, L.L.; Copper absorption and retention in young men at three levels of dietary copper by use of the stable isotope 65Cu. Am. J. Clin. Nutr. 1989, 49, 870–878.
72. Klevay, L.M. Can copper deficiency cause ischemic heart disease In Trace Elements in Man and Animals, TEMA 7; Momcilovic, B., Ed.; Institute for Medical Research and Occupational Health, University of Zagreb: Zagreb, 1991.
73. Hegsted, D.M.; Nicolosi, R.J. Do formula diets attenuate the serum cholesterol response to dietary fats J. Vasc. Med. Biol. 1990, 2, 69–73.
74. Vivoli, G.; Bergomi, M.; Rovesti, S.; Pinotti, M.; Caselgrandi, E.; Zinc, copper, and zinc- or copper-dependent enzymes in human hypertension. Biol. Trace Elem. Res. 1995, 49, 97–106.
75. Bergomi, M.; Rovesti, S.; Vinceti, M.; Vivoli, R.; Caselgrandi, E.; Vivoli, G. Zinc and copper status and blood pressure. J. Trace Elem. Med. Biol. 1997, 11, 166–169.
76. Klevay, L.M.; Measured copper and zinc in body fluids. J. Trace Elem. Med. Biol. 1998, 12, 1.
77. Russo, C.; Olivieri, O.; Girelli, D.; Faccini, G.; Zenari, M.L.; Lombardi, S.; Corrocher, R.; Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J. Hypertens. 1998, 16, 1267–1271.
78. Wang, X.L.; Adachi, T.; Sim, A.S.; Wilcken, D.E. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 1915–1921.
79. Dubick, M.A.; Keen, C.L.; DiSilvestro, R.A.; Eskelson, C.D.; Ireton, J.; Hunter, G.C.; Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc. Soc. Exp. Biol. Med. 1999, 220, 39–45.
80. Landmesser, U.; Merten, R.; Spiekermann, S.; Buttner, K.; Drexler, H.; Hornig, B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000, 101, 2264–2270.
81. Wester, P.O.; Trace elements in human myocardial infarction determined by neutron activation analysis. Acta Med. Scand. 1965, 178, 765–788.
82. Anderson, T.W.; Neri, L.C.; Schreiber, G.B.; Talbot, F.D.; Zdrojewski, A.; Ischemic heart disease, water hardness and myocardial magnesium. Can. Med. Assoc. J. 1975, 113, 199–203.
83. Chipperfield, B.; Chipperfield, J.R. Differences in metal content of the heart muscle in death from ischemic heart disease. Am. Heart J. 1978, 95, 732–737.
84. Tilson, M.D.; Decreased hepatic copper levels. A possible chemical marker for the pathogenesis of aortic aneurysms in man. Arch. Surg. 1982, 117, 1212–1213.
85. Aalbers, T.G. Cardiovascular Diseases and Trace Elements; Drukkerij Blok en Zonen: Dieren, 1984.
86. Penttilä, O.; Neuvonen, P.J.; Himberg, J.J.; Siltanen, P.; Järvinen, A.; Merikallio, E.; Auricular myocardial cation concentrations in certain heart diseases in man. Trace Elem. Med. 1986, 3, 47–51.
87. Zama, N.; Towns, R.L. Cardiac copper, magnesium, and zinc in recent and old myocardial infarction. Biol. Trace Elem. Res. 1986, 10, 201–208.
88. Kinsman, G.D.; Howard, A.N.; Stone, D.L.; Mullins, P.A.; Studies in copper status and atherosclerosis. Biochem. Soc. Trans. 1990, 18, 1186–1188.
89. Oster, O.; Dahm, M.; Oelert, H. Element concentrations (selenium, copper, zinc, iron, magnesium, potassium, phosphorous) in heart tissue of patients with coronary heart disease correlated with physiological parameters of the heart. Eur. Heart J. 1993, 14, 770–774.
90. Mielcarz, G.; Howard, A.N.; Mielcarz, B.; Williams, N.R.; Rajput-Williams, J.; Nigdigar, S.V.; Stone, D.L. Leucocyte copper, a marker of copper body status is low in coronary artery disease. J. Trace Elem. Med. Biol. 2001, 15, 31–35.
91. Dann, W.J.; Darby, W.J. The appraisal of nutritional status (nutriture) in humans; with especial reference to vitamin deficiency disease. Physiol. Rev. 1945, 25, 326–346.
92. Golden, M.H.N. Severe malnutrition. In Oxford Textbook of Medicine, 3rd Ed.; Weatherall, D.J., Ledingham, J.G., Warrell, D.A., Eds.; Oxford University Press: Oxford, 1996; 1278–1296.
93. Klevay, L.M. Advances in cardiovascularcopper research. In Trace Elements in Nutrition, Health and Disease, First International Bio- Minerals Symposium, Apr 19, 2001; Schrauzer, G.N., Ed.; Institut Rosell: Montreal, Canada, 2002; 64–71.
94. Klevay, L.M. The Lifestyle Heart Trial. Nutr. Rev. 1992, 50, 29.
95. Klevay, L.M.; Extra dietary copper inhibits LDL oxidation. Am. J. Clin. Nutr. 2002, 76, 687–688.
96. Klevay, L.M.; Dietary copper and risk of coronary heart disease. Am. J. Clin. Nutr. 2000, 71, 1213–1214.
97. Spencer, J.C.; Direct relationship between the body’s copper/zinc ratio, ventricular premature beats, and sudden coronary death. Am. J. Clin. Nutr. 1979, 32, 1184–1185.
98. Milachowski, K.A.; Investigation of ischaemic necrosis of the femoral head with trace elements. Int. Orthop. 1988, 12, 323–330.
99. Conlan, D.; Korula, R.; Tallentire, D. Serum copper levels in elderly patients with femoralneck fractures. Age Ageing 1990, 19, 212–214.
100. Milachowski, K.A.; Matzen, K.A. Mineral- und Spurenelementstoffwechselstӧrungen bei der Koxarthrose. Z. Orthop. 1982, 120, 828–832.
101. Howard, G.; Andon, M.; Bracker, M.; Saltman, P.; Strause, L. Low serum copper, a risk factor additional to low dietary calcium in postmenopausal bone loss. J. Trace Elem. Exp. Med. 1992, 5, 23–31.
102. Strause, L.; Saltman, P.; Smith, K.T.; Bracker, M.; Andon, M.B.; Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J. Nutr. 1994, 124, 1060–1064.
103. Eaton-Evans, J.; McIlrath, E.M.; Jackson, W.E.; McCartney, H.; Strain, J.J.; Copper supplementation and the maintenance of bone mineral density in middle-aged women. J. Trace Elem. Exp. Med. 1996, 9, 87–94.
104. Anon Copper metabolism in premature and low-birth-weight neonates. Nutr. Rev. 1981, 39, 333–336.
105. Percival, S.S.; Bowser, E.; Wagner, M. Reduced copper enzyme activities in blood cells of children with cystic fibrosis. Am. J. Clin. Nutr. 1995, 62, 633–638.
106. Percival, S.S.; Kauwell, G.P.; Bowser, E.; Wagner, M. Altered copper status in adult men with cystic fibrosis. J. Am. Coll. Nutr. 1999, 18, 614–619.
107. Best, K.; McCoy, K.; Gemma, S.; DiSilvestro, R.A. Copper enzyme activities in cystic fibrosis before and after copper supplementation plus or minus zinc. Metabolism 2004, 53, 37–41.
108. Mennigen, R.; Kusche, J.; Streffer, C.; Krakamp, B. Diamine oxidase activities in the large bowel mucosa of ulcerative colitis patients. Agents Actions 1990, 30, 264–266.
109. Klevay, L.M. The role of copper, zinc, and other chemical elements in ischemic heart disease. In Metabolism of Trace Metals in Man; Rennert, O.M., Chan, W.Y., Eds.;CRCPress: Boca Raton, FL, 1984; 129–157.
110. van Ravesteyn, A.H. Metabolism of copper in man. Acta Med. Scand. 1944, 118, 163–196.
111. Araya, M.; McGoldrick, M.C.; Klevay, L.M.; Strain, J.J.; Robson, P.; Nielsen, F.; Olivares, M.; Pizarro, F.; Johnson, L.A.; Poirier, K.A. Determination of an acute no-observedadverse- effect level (NOAEL) for copper in water. Regul. Toxicol. Pharmacol. 2001, 34, 137–145.
112. Araya, M.; Chen, B.; Klevay, L.M.; Strain, J.J.; Johnson, L.; Robson, P.; Shi, W.; Nielsen, F.; Zhu, H.; Olivares, M.; Pizarro, F.; Haber, L.T.; Confirmation of an acute no-observed-adverseeffect and low-observed-adverse-effect level for copper in bottled drinking water in a multi-site international study. Regul. Toxicol. Pharmacol. 2003, 38, 389–399.
113. Klevay, L.M. The illness and death of a female hyena poisoned by zinc ingested as pennies. J. Zoo Wildl. Med. 2000, 31, 289–290.
114. Hoogenraad, T.U.; Dekker, A.W.; Van den Hamer, C.J. Copper responsive anemia, induced by oral zinc therapy in a patient with acrodermatitis enteropathica. Sci. Total Environ. 1985, 42, 37–43.
115. Klevay, L.M.; Using zinc to remove copper from pediatric patients with Wilson’s disease. J. Lab. Clin. Med. 2001, 138, 214.
116. Reiser, S.; Ferretti, R.J.; Fields, M.; Smith, J.C. Jr.; Role of dietary fructose in the enhancement of mortality and biochemical changes associated with copper deficiency in rats. Am. J. Clin. Nutr. 1983, 38, 214–222.
117. Fields, M.; Ferretti, R.J.; Smith, J.C., Jr.; Reiser, S. The interaction of type of dietary carbohydrates with copper deficiency. Am. J. Clin. Nutr. 1984, 39, 289–295.
118. Oberleas, D. Phytates. In Toxicants Occurring Naturally in Foods, 2nd Ed.; Strong, F.M., et al., Eds.; National Academy of Sciences: Washington, DC, 1973; 363.